Search - tctmd.com

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

News Daily News

El Uso ‘Apropiado’ de la Revascularización Varía en Pacientes con EAC Estable

Caitlin E. Cox

October 12, 2012

News Daily News

‘Appropriate’ Use of Revascularization Varies in Stable CAD Patients

Caitlin E. Cox

October 12, 2012

Presentation

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Presenter: Dennis T. Ko

October 10, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Jason Kahn

March 05, 2012

Advertisement

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

血运重建可能会令无法进行适当性评分的冠脉疾病患者受益

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

Statins More Beneficial Before PCI Than After in ACS Patients

Meta Análisis de los Beneficios Temporales del Tratamiento con Estatinas en Pacientes víctimas de SCA sometidos a PCI

How Population-Based Studies Can Promote Cardiovascular Innovations

Implications of Stent Over- and Under-utilization by AUC Criteria: Toronto Experience

加拿大的心导管阳性检出率远高于纽约州

El Rendimiento Diagnóstico de la Catererización en Canadá es Mucho Más Alto que en el Estado de Nueva York

Diagnostic Yield of Catheterization in Canada Much Higher Than in New York State

Prevalence and Extent of Obstructive CAD Among Patients Undergoing Elective Coronary Catheterization in New York State and Ontario

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

El Uso ‘Apropiado’ de la Revascularización Varía en Pacientes con EAC Estable

‘Appropriate’ Use of Revascularization Varies in Stable CAD Patients

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Statins Reduce Late Restenosis After SES Implantation

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content